Berger Montague has filed a class action lawsuit against Skechers U.S.A., accusing senior executives of undervaluing shares during a $9.4 billion take-private deal in 2025. The complaint claims Skechers' management, including CEO Robert Greenberg, manipulated financial projections and withheld key information to justify a $63 per share buyout price, which was artificially low. Investors who sold shares or accepted the merger price during the class period may have suffered losses and can apply to be lead plaintiffs by December 21, 2026. This case highlights potential corporate governance issues and could impact investor confidence in Skechers' management.
Regarding the class action lawsuit involving Skechers U.S.A., here is Pluang's market snapshot for the Consumer Cyclical sector as of Oct 23, 2026 18:51 WIB: Out of 134 priced US stocks, 30 rose while 100 fell. Lululemon Athletica Inc (LULU) traded at USD 102.40 with a 5% sell to 95% buy order activity and a typical hold time of 107 days, contrasting with ON Holding AG (ONON) at USD 33.47 and Caesars Entertainment Inc (CZR) at USD 28.62, both down about 1.5% for the day and held typically for less than 35 days.
Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
